Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about EAAT2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Gene Symbol | EAAT2 |
| Function | EAAT2 (also known as GLT-1 or SLC1A2) is a 574-amino acid transmembrane protein that functions as the primary glutamate transporter in the brain. |
| Subcellular Localization | Plasma membrane, astrocytic processes ensheathing synapses ; Protein Family : Ex |
| Molecular Weight | 65 kDa |
| Amino Acids | 574 aa |
| Pathways | neurotrophin signaling, glutamate signaling, circadian regulation, Tau Phosphorylation |
| GeneCards | EAAT2 |
| Human Protein Atlas | EAAT2 |
| Associated Diseases | ALS, Alzheimer, epilepsy, neurodegeneration, Parkinson |
| Known Drugs/Compounds | memantine, rapamycin |
| Interactions | ALZHEIMER, AQP4, BDNF, BMAL1, CREB, GABA |
| KG Connections | 97 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
EAAT2["EAAT2"]
ALZHEIMER["ALZHEIMER"]
EAAT2 -->|"activates"| ALZHEIMER
Alzheimer_S_Disease["Alzheimer'S Disease"]
EAAT2 -->|"activates"| Alzheimer_S_Disease
disease["disease"]
EAAT2 -->|"activates"| disease
ALZHEIMER_S["ALZHEIMER'S"]
EAAT2 -->|"activates"| ALZHEIMER_S
GLUTAMATE["GLUTAMATE"]
EAAT2 -->|"activates"| GLUTAMATE
EXCITOTOXICITY["EXCITOTOXICITY"]
EAAT2 -->|"activates"| EXCITOTOXICITY
ALZHEIMER["ALZHEIMER"]
EAAT2 -->|"inhibits"| ALZHEIMER
Alzheimer_S_Disease["Alzheimer'S Disease"]
EAAT2 -->|"inhibits"| Alzheimer_S_Disease
disease["disease"]
EAAT2 -->|"inhibits"| disease
ALZHEIMER_S["ALZHEIMER'S"]
EAAT2 -->|"inhibits"| ALZHEIMER_S
GLUTAMATE["GLUTAMATE"]
EAAT2 -->|"inhibits"| GLUTAMATE
EXCITOTOXICITY["EXCITOTOXICITY"]
EAAT2 -->|"inhibits"| EXCITOTOXICITY
Tau_Phosphorylation["Tau Phosphorylation"]
EAAT2 -->|"activates"| Tau_Phosphorylation
Astrocytes["Astrocytes"]
EAAT2 -->|"activates"| Astrocytes
Astrocyte["Astrocyte"]
EAAT2 -->|"activates"| Astrocyte
Reactive_Oxygen_Species["Reactive Oxygen Species"]
EAAT2 -->|"activates"| Reactive_Oxygen_Species
PARKINSON["PARKINSON"]
EAAT2 -->|"activates"| PARKINSON
Parkinson_s_Disease["Parkinson's Disease"]
EAAT2 -->|"activates"| Parkinson_s_Disease
PARKINSON_S["PARKINSON'S"]
EAAT2 -->|"activates"| PARKINSON_S
NF__B["NF-kappaB"]
EAAT2 -->|"activates"| NF__B
NEUROTOXICITY["NEUROTOXICITY"]
EAAT2 -->|"activates"| NEUROTOXICITY
B_CELLS["B CELLS"]
EAAT2 -->|"activates"| B_CELLS
NF__B_P65["NF-KappaB P65"]
EAAT2 -->|"activates"| NF__B_P65
oxidative_stress["oxidative stress"]
EAAT2 -->|"activates"| oxidative_stress
TNF__["TNF-alpha"]
EAAT2 -->|"activates"| TNF__
CELL_DEATH["CELL DEATH"]
EAAT2 -->|"regulates"| CELL_DEATH
GLUTAMATE["GLUTAMATE"]
EAAT2 -->|"regulates"| GLUTAMATE
EXCITOTOXICITY["EXCITOTOXICITY"]
EAAT2 -->|"regulates"| EXCITOTOXICITY
CENTRAL_NERVOUS_SYSTEM["CENTRAL NERVOUS SYSTEM"]
EAAT2 -->|"regulates"| CENTRAL_NERVOUS_SYSTEM
Cognitive_Impairment["Cognitive Impairment"]
EAAT2 -->|"inhibits"| Cognitive_Impairment| Target | Relation | Type | Str |
|---|---|---|---|
| ASTROCYTES | expressed_in | cell_type | 0.95 |
| Glutamate | transports | compound | 0.95 |
| Glutamate transport | catalyzes | process | 0.90 |
| astrocytes | expressed_in | cell_type | 0.75 |
| Alzheimer's disease | interacts_with | disease | 0.70 |
| neurons | expressed_in | cell_type | 0.70 |
| epilepsy | causes | disease | 0.60 |
| PKA | activates | gene | 0.60 |
| NMDA | inhibits | gene | 0.60 |
| GABA | associated_with | gene | 0.60 |
| NMDAR | associated_with | gene | 0.60 |
| NMDAR | activates | gene | 0.60 |
| ubiquitin-proteasome | participates_in | pathway | 0.60 |
| Parkinson | associated_with | disease | 0.60 |
| Alzheimer | associated_with | disease | 0.60 |
| GFAP | biomarker_for | gene | 0.60 |
| HLA | biomarker_for | gene | 0.60 |
| Alzheimer's disease | activates | disease | 0.60 |
| Parkinson's disease | activates | disease | 0.60 |
| YY1 | activates | gene | 0.60 |
| NF-kB signaling | participates_in | pathway | 0.60 |
| IKK | activates | gene | 0.60 |
| TNF | activates | gene | 0.60 |
| oxidative stress response | participates_in | pathway | 0.60 |
| GFAP | activates | gene | 0.60 |
| neurodegeneration | associated_with | disease | 0.60 |
| epilepsy | associated_with | disease | 0.60 |
| ALS | associated_with | disease | 0.60 |
| neurotrophin signaling | participates_in | pathway | 0.55 |
| glutamate signaling | participates_in | pathway | 0.55 |
| GDNF | activates | gene | 0.55 |
| VGLUT1 | inhibits | gene | 0.55 |
| microglia | expressed_in | cell_type | 0.55 |
| TNF | inhibits | gene | 0.55 |
| circadian regulation | participates_in | pathway | 0.55 |
| RNA | inhibits | gene | 0.55 |
| IKK | co_expressed_with | protein | 0.50 |
| TNF | co_expressed_with | gene | 0.50 |
| GLUTAMATE | inhibits | concept | 0.50 |
| EXCITOTOXICITY | inhibits | concept | 0.50 |
| Tau Phosphorylation | activates | pathway | 0.50 |
| Astrocytes | activates | cell_type | 0.50 |
| Astrocyte | activates | cell_type | 0.50 |
| Reactive Oxygen Species | activates | process | 0.50 |
| PARKINSON | activates | gene | 0.50 |
| Parkinson's Disease | activates | disease | 0.50 |
| PARKINSON'S | activates | concept | 0.50 |
| NF-κB | activates | concept | 0.50 |
| NEUROTOXICITY | activates | concept | 0.50 |
| B CELLS | activates | concept | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PSEN1 | interacts_with | gene | 0.95 |
| Insulin | upregulates | entity | 0.90 |
| ALDH1L1 | biomarker_for | gene | 0.60 |
| CD68 | biomarker_for | gene | 0.60 |
| memantine | targets | drug | 0.60 |
| rapamycin | targets | drug | 0.60 |
| APOE4 | expressed_in | gene | 0.55 |
| BMAL1 | activates | gene | 0.55 |
| AQP4 | activates | gene | 0.55 |
| BDNF | activates | gene | 0.55 |
| CREB | activates | gene | 0.55 |
| AQP4 | inhibits | gene | 0.55 |
| NMDA | inhibits | protein | 0.50 |
| manganism | activates | disease | 0.50 |
| EPILEPSY | causes | gene | 0.50 |
| AKT | associated_with | gene | 0.50 |
| GFAP | activates | gene | 0.50 |
| mTOR | expressed_in | entity | 0.50 |
| SLC1A2 | activates | gene | 0.50 |
| NMDA | activates | protein | 0.50 |
| Neurodegeneration | inhibits | disease | 0.50 |
| GABA | inhibits | gene | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning EAAT2 in their description or question text
No additional research found